Swaziland

A snapshot of PrEP scale-up, registration and resources for Swaziland.

  • 1,800-2,300
    Estimated Number of Current PrEP Users

    Aggregates numbers reported from demonstration projects, PEPFAR dashboard and program/country reports where available. This is presented as a range due to difficulty in tracking precise numbers and possible double reporting.

  • 1,300
    PEPFAR PrEP Target in COP 2018

    Targets are set by PEPFAR country teams on an annual basis. Targets do not indicate funding is available for PrEP.

Data Updated: December 31, 2018

Drug Registration Status

  • Gilead's Truvada (TDF/FTC) registration
    Approved
  • Generic versions of TDF/FTC for prevention
    Not submitted

Types of Projects

  • Demonstration projects, which road-test the use of new options in real-world settings—not in a trial site. They have a formal evaluation component that is designed to address specific elements of introduction such as infrastructure needs and ways individuals can integrate it into daily activities.
  • Large-scale implementation initiative — funded/implementer involvement and investment in some or all steps related to comprehensive introduction that may or may not use government clinics as the primary service delivery point – e.g., Kenya’s Jilinde program.

Research, Demonstration and Implementation Projects

Funding

  • USAID
  • The Bill & Melinda Gates Foundation
  • PEPFAR
  • Nike Foundation
  • Heidelberg Institute of Public Health
  • Mylan

Resources for Swaziland